Myeloma & Plasma Cell Dyscrasia


Upon viewing this session, you will be able to:

• identify role and agents for maintenance therapy after autologous stem cell transplant
• evaluate duration of treatment and regimen with immunomodulatory drugs in the non-transplant setting
• review new induction regimens available for multiple myeloma in the non-transplant setting
• discuss novel agents and therapeutic modalities in-development for patients with relapsed/refractory multiple myeloma


  • Cristina Gasparetto


Member Type Price
List Price $30.00
Active, International, Emeritus, and Honorary Members $20.00
Associate, International Associate, Student, and Resident Members $20.00
back to top